Reassessing the Cultural and Psychopharmacological Significance of Banisteriopsis caapital: Preparation, Classification and Use Among the Piaroa of Southern Venezuela

Journal of Psychoactive Drugs

Volumn 40, Issue 3, 2008, Pages 301-307

  Rodd, Robin ^a  

^a JAMES COOK UNIVERSITY   (Australia)

Author keywords

Ayahuasca; Banisteriopsis caapi; Piaroa yopo; carbolines

Indexed keywords

ANTIDEPRESSANT AGENT; BANISTERIOSIS CAAPI EXTRACT; N,N DIMETHYLTRYPTAMINE; PSYCHOSTIMULANT AGENT; UNCLASSIFIED DRUG;

ALTERNATIVE MEDICINE; ARTICLE; BANISTERIOSIS CAAPI; CULTURAL ANTHROPOLOGY; DRUG ISOLATION; EMPATHY; ETHNOPHARMACOLOGY; HUMAN; INDIGENOUS PEOPLE; PHYTOCHEMISTRY; PSYCHOPHARMACOLOGY; VENEZUELA; VISUAL HALLUCINATION;

ALKALOIDS; BANISTERIOPSIS; HALLUCINOGENS; HUMANS; INDIANS, SOUTH AMERICAN; MEDICINE, TRADITIONAL; MONOAMINE OXIDASE INHIBITORS; N,N-DIMETHYLTRYPTAMINE; PLANT EXTRACTS; SHAMANISM; VENEZUELA;

EID: 55349136992     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.2008.10400645     Document Type: Article

References (45)

1. Andritzky, W. 1989. Sociopsychotherapeutic functions of ayahuasca healing in Amazonia. Journal of Psychoactive Drugs 21 (1): 77-89.
2. Buckholtz, N.S. & Boggan, W.O. 1977. Monoamine oxidase inhibition in brain and liver produced by B--carbolines: Structure-activity relationships and substrate specificity. Biochemical Pharmacology 26: 1991-96.
3. Callaway, J.C. 2005.Various alkaloid profiles in decoctions of Banisteriopsis caapi. Journal of Psychoactive Drugs 37 (2): 151-5.
4. Callaway, J.C. & Grob, C.S. 1998. Ayahuasca preparations and serotonin reuptake inhibitors: A potential combination for severe adverse interactions. Journal of Psychoactive Drugs 30 (4): 367-69.
5. Callaway, J.C.; Brito, G.S. & Neves, E. 2005. Phytochemical analyses of Banisteriopsis caapi and Psychotria viridis. Journal of Psychoactive Drugs 37 (2): 145-50.
6. Callaway, J.C.; McKenna, D.J.; Grob, C.S.; Brito, G.S.; Raymon, L.P.; Poland, R.E.; Andrade, E.N. & Andrade, E.O. 1999. Pharmacokinetics of hoasca alkaloids in healthy humans. Journal ofEthnopharmacology 65: 243-56.
7. Colchester, M. & Lister, J. 1978. The Ethnobotany of the Orinoco-Venturari Region: An Introduction. Caracas: Fundación La Salle.
8. Coppens, W. & Cato-David, J. 1971. El yopo entre los Cuiva-Guahibo: Aspectos etnográficos y farmacológicos. Antropológica 28: 3-24.
9. Dobkin de Rios, M., 1984. Hallucinogens: Cross-Cultural Perspectives. Albuquerque: University of New Mexico Press.
10. Downer, J. 2002. Weird Nature: Science is Stranger than Myth. London: BBC.
11. Farzin, D. & Mansouri, N. 2005. Antidepressant-like effect of harmane and other B-carbolines in the mouse forced swim test. European Neuropsychopharmacology 16 (5): 324-8.
12. Fischer, C.G. 1923. Estudio sobre el principio activo del yagé. Ph.D. thesis in Department of Chemistry, Universidad Nacional, Bogotá.
13. Fish, M.S.; Johnson N.M. & Homing, E.C. 1955. Piptadenia alkaloids indole bases of P. Peregrina (L.) Benth. and related species. Journal of the American Chemistry Society 77: 5892-95.
14. Frecska, E. & Kulcsar, Z. 1989. Social bonding in the modulation of the physiology of ritual trance. Ethos 17 (1): 70-87.
15. Freedland, C.S. & Mansbach, R.S. 1999. Behavioral constituents in ayahuasca, an Amazonian psychoactive plant mixture. Drug and Alcohol Dependence 54: 183-94.
16. Gates, B. 1986. La taxonomía de las Malpigiaceas utilizadas en el brebaje del ayahuasca. America Indígena XLVI (1): 49-72.
17. Guánchez, F. 1996. Plantas de Uso Medicianl, Magico y Psicotrópico del Estado Amazonas. Caracas: SADA.
18. Hochstein, F.A. & Paradies, A.M. 1957.Alakaloids of Banisteria caapi and Prestonia amazonicum. Journal of the American Chemical Society LXXIX: 5735-36.
19. Holmstedt, B. & Lindgren, J. 1979. Chemical constituents and pharmacology of South American snuffs. In: D.H. Efron; B. Holmstedt & N S. Kline (Eds.) Ethnopharmacological Search for Psychoactive Drugs. New York: Raven Press.
20. Kleven, M.S. & Woolverton, W.L. 1993. Effects of three monamine uptake inhibitors on behaviour maintained by cocaine or food presentation in rhesus monkeys. Drug and Alcohol Dependence 31: 149-58.
21. Komulainen, H.; Tuomisto, J.; Airaksinen, M.M.; Kari, I.; Petura, P. & Pollari, L. 1980. In vitro inhibition of serotonin, dopamine and noradrenaline in reuptake in rat brain synaptosomes. Acta Pharmacologica et Toxicologica 46: 299-307.
22. Luna, L.E. 1984. The concept of plants as teachers among four mestizo shamans of Iquitos, Northeastern Peru. Journal of Ethnopharmacology II: 135-56.
23. McKenna, D J. & Towers, G.H.N. 1984. Biochemistry and pharmacology of tryptamines and B-carbolines: A minireview. Journalof Psychoactive Drugs 16 (4): 347-58.
24. McKenna, D.J.; Towers, G.H. N. & Abbott, F.S. 1984. Monoamine oxidase inhibitors in South American hallucinogenic plants: Tryptamine and B-carboline constituents of ayahuasca. Journal ofEthnopharmacology 10: 195-223.
25. Naranjo, C. 1979. Psychotropic properties of the harmala alkaloids. In: D.H. Efron; B. Holmstedt & N.S.Kline(Eds.)Ethnopharmacological Search for Psychoactive Drugs. New York: Raven Press.
26. Naranjo, C. 1973. Psychological aspects of the yagé experience in an experimental setting. In: M. Harner (Ed.) Hallucinogens and Shamanism. New York: Oxford University Press.
27. OCEI. 2005. Censo Indígena (2001). Caracas: OCEI.
28. Ott, J. 1996. Pharmacotheon: Entheogenic Drugs, Their Plant Sources and History. Kennewick, WA: Natural Products Co.
29. Overing, J. 1975. The Piaroa. A People of the Orinoco Basin: A Study in Kinship and Marriage. Oxford: Clarendon Press.
30. Pennes, H.H. & Hoch, PH. 1957. Psychotomimetics, clinical and theoretical considerations: Harmine, WIN-2299 and nalline. American Journal of Psychiatry 113: 887-92.
31. Pimpinella, G. & Palmery, M. 1995. Interaction of B-carbolines with central dopaminergic transmission in mice: Structure-activity relationships. Neuroscience Letters 189: 121-24.
32. Reichel-Dolmatoff, G. 1972. The cultural context of an aboriginal hallucinogen: Banisteriopsis caapi. In: P. Furst (Ed.) Flesh of the Gods. New York: Praeger Publishers.
33. Riba, J. & Barbanoj, MJ. 1998. A pharmacological study of ayahuasca in healthy volunteers. Bulletin of the Multidisciplinary Association for Psychedelic Studies 8 (3): 12-15.
34. Riba, J.; Anderer, P.; Jane, F.; Saletu, B. & Barbanoj, M. 2004. Effects of the South American psychoactive beverage Ayahuasca on regional brain electrical activity in humans: A functional neuroimaging study using low-resolution electromagnetic tomography. Neuro psychobiology 50: 89-101.
35. Riba, J.; Rodriguez, F.A.; Urbano, G.; Morte, A.; Antonijoan, R.; Montero, M.; Callaway, J.C. & Barbanoj, M.J. 2001. Subjective effects and tolerability of the South American psychoactive beverage ayahuasca in healthy volunteers. Psychopharmacology 7 (6): 453-60.
36. Rivier, L. & Lindgren, J. 1972. “Ayahuasca." The South American hallucinogenic drink: An ethnobotanical and chemical investigation. JournalofEconomicBotany 23 (1): 101-29.
37. Rodd, R. 2002. Snuff synergy: The preparation, use and pharmacology of yopo and Banisteriopsis caapi among the Piaroa of Southern Venezuela. Journal of Psychoactive Drugs 34 (3): 273-80.
38. Schultes, R.E. 1979. The botanical origins of South American snuffs. In: D.H. Efron; B. Holmstedt & N.S.Kline(Eds.) Ethnopharmacological Search for Psychoactive Drugs. New York: Raven Press.
39. Schultes, R.E. 1957. The identity of t he malpighiaceous narcotics of South America. Botanical Museum Leaflets 18(1): 1-56.
40. Slotkin, T.A.; DiStefano, V. & Au, W.Y.W. 1970. Blood levels and urinary excretion of harmine and its metabolites in man and rats. Journal of Pharmacology and Experimental Therapeutics 173: 26-30.
41. Spruce, R. 1908. Notes of a Botanist on the Amazon and Andes, Vol. II. London: Macmillan.
42. Spruce, R. 1873. On some remarkable narcotics ofthe Amazon valley and Orinoco. August Geographic Review I (55): 184-93.
43. Stromberg, V.L. 1954. The isolation of bufotenine from Piptadenia peregrina. Journal ofthe American Chemistry Society 76: 1707.
44. Stuckey, D.E.; Lawson, R. & Luna, L.E. 2005. EEG gamma coherence and other correlates of subjective reports during ayahuasca experiences. Journal of Psychoactive Drugs 37 (2): 163-78.
45. Zent, S. 1999.The quandary of conserving ethnoecological knowledge: A Piaroa example. In: T.L. Gragson & B G. Blount (Eds.) Ethnoecology: Knowledge, Resources, and Rights. London: University of Georgia Press.